CONNECT WITH US
HealthTech

HealthTech

Longevity platform Hone Health nabs $228M to build out offerings

Fierce Healthcare logo

Published on

Add as a preferred source on Google
Longevity platform Hone Health nabs $228M to build out offerings

Hone Health, a physician-led virtual longevity care platform, has raised $228 million.

The investment is structured as a combination of equity and growth financing. The $28 million series A extension was led by MarcyPen Capital Partners, with participation from Pentland Ventures, Kinship Ventures, Hanwha, Gannet Capital, humbition and Comma Capital. Other angel investors also participated, including the Jonas brothers. The $200 million in growth financing came from General Catalyst’s Customer Value Fund.

Hone will use the investment to support a number of expansions. It plans to launch more programming for metabolic health, PMOS, inflammation and immunity, and to launch a physician-supervised peptide program. It will add more diagnostics, including coronary CT angiography and gut microbiome analysis.

Hone also plans to continue building out its AI operating system that brings data together to help personalize care. And, it plans to build out clinical trial infrastructure to support pharma partners.

“Longevity is thought of as this super exotic thing. … I actually think longevity is now becoming primary care,” Saad Alam, co-founder and CEO of Hone, told Fierce Healthcare.

It costs $65 to test for 70 biomarkers with Hone, followed by a clinician consult with the option to add more diagnostics. Labs, health history, symptoms and medications are run through its AI, which then gives providers treatment recommendations. Hone can keep adding additional diagnostics and medications, per Alam, “and the AI gets smarter as we get more patients into that system.”

From there, patients can become subscribers. A subscription is $150 a month, plus the cost of medications.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.